Interleukin-1?-converting enzyme/caspase-1 in human osteoarthritic tissues: Localization and role in the maturation of interleukin-1? and interleukin-18
Open Access
- 1 August 1999
- journal article
- basic science
- Published by Wiley in Arthritis & Rheumatism
- Vol. 42 (8) , 1577-1587
- https://doi.org/10.1002/1529-0131(199908)42:8<1577::aid-anr3>3.0.co;2-z
Abstract
Objective To study the expression and production of interleukin‐1β–converting enzyme (ICE) in human normal and osteoarthritic (OA) cartilage and synovium, quantitate the level of ICE in OA chondrocytes, and examine the relationship between the topographic distribution of ICE, interleukin‐1β (IL‐1β), and IL‐18, as well as apoptosis of chondrocytes. Methods The expression and synthesis of ICE were investigated in human normal and OA cartilage and synovial membrane using in situ hybridization and immunohistochemical methods. The intracellular level of ICE in OA chondrocytes was also measured by enzyme‐linked immunosorbent assay (ELISA). Furthermore, the topographic relationship between the presence of ICE and mature IL‐1β and IL‐18 was examined by immunohistochemistry, and apoptotic chondrocytes by the TUNEL technique. Results ICE was expressed and synthesized in both human synovial membrane and cartilage, with a significantly greater number of cells staining positive in OA tissue than in normal tissue. ICE production was preferentially located in the superficial and upper intermediate layers of articular cartilage. With a specific ELISA, a level of 230.2 ± 22.5 pg/5 × 105 cells (mean ± SEM) of ICE was found in OA chondrocytes. In cartilage, IL‐1β and IL‐18 stained positive at a topographic location similar to that of ICE. The production of mature IL‐1β in OA cartilage explants and chondrocytes was completely blocked by treatment with a specific ICE inhibitor, which also markedly diminished the number of IL‐18–positive cells. The data show that there was no close relationship between the presence of ICE and the presence of apoptotic chondrocytes in OA cartilage. Conclusion This study shows, for the first time, the presence of active ICE in human articular cartilage, with a markedly increased cellular level in OA tissue. The relationship between active IL‐1β and ICE suggests that ICE may promote OA progression by activating this proinflammatory cytokine. The role of IL‐18 in pathologic cartilage is discussed.Keywords
This publication has 37 references indexed in Scilit:
- Chondroprotective effect of intraarticular injections of interleukin‐1 receptor antagonist in experimental osteoarthritis. Suppression of collagenase‐1 expressionArthritis & Rheumatism, 1996
- The new collagenase, collagenase-3, is expressed and synthesized by human chondrocytes but not by synoviocytes. A role in osteoarthritis.Journal of Clinical Investigation, 1996
- Cloning of a new cytokine that induces IFN-γ production by T cellsNature, 1995
- Expression, Refolding, and Autocatalytic Proteolytic Processing of the Interleukin-1β-converting Enzyme PrecursorJournal of Biological Chemistry, 1995
- Altered Cytokine Export and Apoptosis in Mice Deficient in Interleukin-1β Converting EnzymeScience, 1995
- Metalloprotease activity, phospholipase A2 activity and cytokine concentration in osteoarthritis synovial fluidsOsteoarthritis and Cartilage, 1993
- Articular chondrocytes secrete IL-1, express membrane IL-1, and have IL-1 inhibitory activityCellular Immunology, 1992
- Activation of interleukin‐ 1β by a co‐induced proteaseFEBS Letters, 1989
- Development of criteria for the classification and reporting of osteoarthritis: Classification of osteoarthritis of the kneeArthritis & Rheumatism, 1986
- Release of interleukin‐1 from human synovial tissue in vitroArthritis & Rheumatism, 1985